BABYLON HOLDINGS LIMITED

(BBLN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/11/2022 05/12/2022 05/13/2022 05/16/2022 05/17/2022 Date
1.12(c) 1.21(c) 1.16(c) 1.21(c) 1.12 Last
818 030 2 199 359 1 572 005 916 099 1 256 896 Volume
-13.85% +8.04% -4.13% +4.31% -7.44% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 1 069 M - -
Net income 2022 -391 M - -
Net Debt 2022 356 M - -
P/E ratio 2022 -1,10x
Yield 2022 -
Sales 2023 1 552 M - -
Net income 2023 -367 M - -
Net Debt 2023 391 M - -
P/E ratio 2023 -1,25x
Yield 2023 -
Capitalization 464 M 464 M -
EV / Sales 2022 0,77x
EV / Sales 2023 0,55x
Nbr of Employees 2 573
Free-Float 44,9%
More Financials
Company
Babylon Holdings Limited is a digital health company. The Company is engaged in developing healthcare services accessible to consumers on digital devices platforms. It provides technology solutions to medical professionals by automating routine tasks for the care of patients. It also uses its technology to help consumers become more informed about diseases. The Company offers its digital value-based care (VCB)... 
More about the company
Ratings of Babylon Holdings Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about BABYLON HOLDINGS LIMITED
05/16Canaccord Genuity Adjusts Babylon Holdings' Price Target to $5 From $8, Reiterates Buy ..
MT
05/13Citigroup Adjusts Babylon Holdings' Price Target to $1.50 From $5, Keeps Neutral Rating
MT
05/12Babylon Holdings Q1 Net Loss Widens as Revenue Increases; Lifts 2022 Revenue Outlook; S..
MT
05/12Earnings Flash (BBLN) BABYLON HOLDINGS LIMITED Posts Q1 Revenue $266.4M, vs. Street Est..
MT
05/12Babylon Delivers Massive Growth and Adjusted EBITDA Margin Improvement in the First Qua..
BU
05/12Babylon Holdings Limited Reports Earnings Results for the First Quarter Ended March 31,..
CI
05/12Babylon Holdings Limited Revises Revenue Guidance for the Year 2022
CI
05/09Babylon Announces Participation at the Bank of America Securities 2022 Healthcare Confe..
BU
04/28Berenberg Bank Initiates Babylon Holdings at Hold With $5.50 Price Target
MT
04/25Babylon Holdings Reaffirms Outlook
MT
04/25Babylon Holdings Limited Reiterates Q1 Guidance and 12 May Earnings Call
BU
04/22Babylon Holdings Hits Record Low on Heavy Volume
MT
04/12Babylon Announces First Quarter 2022 Financial Results Conference Call
BU
04/07Babylon Announces Filing and Availability of Annual Report on Form 20-F
BU
03/31Babylon's Integration With Higi Accelerates Momentum With Its AI Technology Now Availab..
BU
More news
News in other languages on BABYLON HOLDINGS LIMITED
05/12La perte nette de Babylon Holdings au 1er trimestre se creuse alors que le chiffre d'af..
05/12Babylon Holdings Limited révise ses prévisions de revenus pour l'année 2022
05/12Babylon Holdings Limited annonce ses résultats financiers pour le premier trimestre clo..
04/25Babylon Holdings réaffirme ses perspectives
04/22Babylon Holdings atteint un niveau record en raison d'un volume important
More news
Analyst Recommendations on BABYLON HOLDINGS LIMITED
More recommendations
Chart BABYLON HOLDINGS LIMITED
Duration : Period :
Babylon Holdings Limited Technical Analysis Chart | BBLN | JE00BLB56359 | MarketScreener
Technical analysis trends BABYLON HOLDINGS LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 1,12 $
Average target price 4,75 $
Spread / Average Target 324%
EPS Revisions
Managers and Directors
Ali Parsadoust Chairman & Chief Executive Officer
Charlie Steel Chief Financial Officer
Steve Davis Chief Technology Officer
Darshak Sanghavi Global Chief Medical Officer
Per Brilioth Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
BABYLON HOLDINGS LIMITED-80.79%502
VEEVA SYSTEMS INC.-35.93%25 117
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED-37.48%7 089
OMNICELL, INC.-39.59%4 818
PRO MEDICUS LIMITED-33.79%2 986
EVOLENT HEALTH, INC.8.60%2 632